Company Vertex Pharmaceuticals Incorporated

Equities

VRTX

US92532F1003

Biotechnology & Medical Research

Market Closed - Nasdaq 21:00:00 24/05/2024 BST 5-day change 1st Jan Change
457 USD +1.36% Intraday chart for Vertex Pharmaceuticals Incorporated +2.64% +12.30%

Business Summary

Vertex Pharmaceuticals Incorporated specializes in the research, development and marketing of micromolecular drugs primarily for the treatment of cancers, viral, inflammatory and auto-immune diseases.

Net sales are distributed geographically as follows: the United States (61.2%), Europe (31.5%) and other (7.3%).

Number of employees: 5,400

Sales per Business

USD in Million2022Weight2023Weight Delta
Pharmaceutical
100.0 %
8,931 100.0 % 9,869 100.0 % +10.51%

Sales per region

USD in Million2022Weight2023Weight Delta
United States
61.2 %
5,699 63.8 % 6,040 61.2 % +5.98%
Europe
31.5 %
2,706 30.3 % 3,109 31.5 % +14.91%
Other
7.3 %
526 5.9 % 720 7.3 % +36.87%

Managers

Managers TitleAgeSince
Chief Executive Officer 51 31/01/17
Chairman 68 07/07/09
Director of Finance/CFO 55 09/04/19
Chief Tech/Sci/R&D Officer - 31/12/18
Chief Tech/Sci/R&D Officer 61 30/04/19
Chief Operating Officer 58 03/09/12
Chief Tech/Sci/R&D Officer - 31/12/15
Chief Tech/Sci/R&D Officer 58 30/06/20
Chief Tech/Sci/R&D Officer 59 31/12/14
Investor Relations Contact - 31/08/22

Members of the board

Members of the board TitleAgeSince
Director/Board Member 68 07/06/17
Chairman 68 07/07/09
Director/Board Member 64 31/12/97
Director/Board Member 62 20/02/19
Director/Board Member 50 04/10/23
Director/Board Member 55 17/06/15
Director/Board Member 59 02/06/20
Director/Board Member 55 17/05/22
Director/Board Member 67 12-04
Chief Executive Officer 51 31/01/17

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 258,053,387 257,764,837 ( 99.89 %) 0 99.89 %

Shareholders

NameEquities%Valuation
Capital Research & Management Co. (World Investors)
10.03 %
25,902,938 10.03 % 10 302 M $
Capital Research & Management Co. (World Investors)
9.898 %
25,567,184 9.898 % 10 168 M $
Vanguard Fiduciary Trust Co.
8.779 %
22,676,518 8.779 % 9 018 M $
BlackRock Advisors LLC
6.648 %
17,173,572 6.648 % 6 830 M $
12,006,483 4.648 % 4 775 M $
Fidelity Management & Research Co. LLC
4.132 %
10,673,520 4.132 % 4 245 M $
AllianceBernstein LP
2.837 %
7,327,172 2.837 % 2 914 M $
JPMorgan Investment Management, Inc.
2.318 %
5,986,553 2.318 % 2 381 M $
Geode Capital Management LLC
2.250 %
5,813,036 2.250 % 2 312 M $
Capital Research & Management Co. (Global Investors)
2.224 %
5,743,882 2.224 % 2 284 M $
NameEquities%Valuation
Bram Bradesco Asset Management S/A DTVM
0.000224 %
2,314 0.000224 % 227 690 $
XP Allocation Asset Management Ltda.
0.000070 %
722 0.000070 % 71 042 $
Santander Brasil Gestão de Recursos Ltda.
0.000017 %
177 0.000017 % 17 416 $

Company contact information

Vertex Pharmaceuticals, Inc.

50 Northern Avenue

02210, Boston

+617 341 6100

http://www.vrtx.com
address Vertex Pharmaceuticals Incorporated(VRTX)
  1. Stock Market
  2. Equities
  3. VRTX Stock
  4. Company Vertex Pharmaceuticals Incorporated